Naoshad Muhammad

1.1k total citations
26 papers, 799 citations indexed

About

Naoshad Muhammad is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Naoshad Muhammad has authored 26 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Naoshad Muhammad's work include Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (3 papers) and RNA modifications and cancer (3 papers). Naoshad Muhammad is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Cancer Cells and Metastasis (3 papers) and RNA modifications and cancer (3 papers). Naoshad Muhammad collaborates with scholars based in United States, India and Saudi Arabia. Naoshad Muhammad's co-authors include Robert Steele, Ratna B. Ray, Sourav Bhattacharya, T. Scott Isbell, Nancy J. Phillips, Huma Naz, Torki A. Zughaibi, Mohd Suhail, Mohammad Tarique and Guangyong Peng and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Naoshad Muhammad

23 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Naoshad Muhammad United States 15 459 316 134 84 70 26 799
Shuqiang Yue China 16 465 1.0× 265 0.8× 120 0.9× 105 1.3× 52 0.7× 28 802
Zhenhua Ni China 17 494 1.1× 219 0.7× 115 0.9× 103 1.2× 57 0.8× 44 801
Carrie Cartwright United States 15 444 1.0× 244 0.8× 194 1.4× 49 0.6× 109 1.6× 24 857
Rachana Garg United States 16 679 1.5× 228 0.7× 177 1.3× 78 0.9× 54 0.8× 24 970
Subhayan Sur United States 18 485 1.1× 292 0.9× 91 0.7× 83 1.0× 48 0.7× 35 821
Xuanfu Xu China 14 470 1.0× 243 0.8× 186 1.4× 69 0.8× 76 1.1× 25 820
Fangtian Fan China 18 414 0.9× 192 0.6× 142 1.1× 63 0.8× 115 1.6× 44 760

Countries citing papers authored by Naoshad Muhammad

Since Specialization
Citations

This map shows the geographic impact of Naoshad Muhammad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Naoshad Muhammad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Naoshad Muhammad more than expected).

Fields of papers citing papers by Naoshad Muhammad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Naoshad Muhammad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Naoshad Muhammad. The network helps show where Naoshad Muhammad may publish in the future.

Co-authorship network of co-authors of Naoshad Muhammad

This figure shows the co-authorship network connecting the top 25 collaborators of Naoshad Muhammad. A scholar is included among the top collaborators of Naoshad Muhammad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Naoshad Muhammad. Naoshad Muhammad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Suhail, Mohd, Shams Tabrez, Mohammad Tarique, et al.. (2025). Unlocking the therapeutic potential of polyphenols: Promising advances and future directions in pancreatic cancer treatment. Seminars in Oncology. 52(4). 152353–152353. 1 indexed citations
2.
3.
Muhammad, Naoshad, et al.. (2025). An Overview of Latest Developments in DLBCL its Pathogenesis, Immune Significance, Prognosis and Targets. 6(3). 37–49. 3 indexed citations
4.
Chouhan, Surbhi, et al.. (2024). Sirtuins as Key Regulators in Pancreatic Cancer: Insights into Signaling Mechanisms and Therapeutic Implications. Cancers. 16(23). 4095–4095. 1 indexed citations
5.
Muhammad, Naoshad, et al.. (2024). Cancer Stem Cells Niche Regulation Within the Tumor Microenvironment. 5(2). 25–37. 1 indexed citations
6.
Chouhan, Surbhi, et al.. (2024). Molecular Sentinels: Unveiling the Role of Sirtuins in Prostate Cancer Progression. International Journal of Molecular Sciences. 26(1). 183–183. 6 indexed citations
7.
Muhammad, Naoshad, et al.. (2024). The Role of Cancer-Specific Target Antigens in CAR T Cell Therapy in Hematological Malignancies. 5(2). 61–67. 18 indexed citations
8.
Tarique, Mohammad, Huma Naz, Mohd Suhail, et al.. (2023). Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy. Frontiers in Immunology. 14. 1138145–1138145. 26 indexed citations
9.
Muhammad, Naoshad, Jennifer Stanley, Kevin Cho, et al.. (2022). Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy. Cancer Research. 82(24). 4515–4527. 14 indexed citations
10.
Muhammad, Naoshad, Mohammad Tarique, Huma Naz, et al.. (2022). The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer. Cells. 11(14). 2209–2209. 62 indexed citations
11.
Tarique, Mohammad, Mohd Suhail, Huma Naz, et al.. (2022). Where do T cell subsets stand in SARS-CoV-2 infection: an update. Frontiers in Cellular and Infection Microbiology. 12. 964265–964265. 7 indexed citations
12.
Floberg, John M., Jin Zhang, Naoshad Muhammad, et al.. (2021). Standardized Uptake Value for 18F-Fluorodeoxyglucose Is a Marker of Inflammatory State and Immune Infiltrate in Cervical Cancer. Clinical Cancer Research. 27(15). 4245–4255. 18 indexed citations
13.
Inkman, Matthew, Naoshad Muhammad, Christopher A. Miller, et al.. (2021). HPV transcript expression affects cervical cancer response to chemoradiation. JCI Insight. 6(16). 14 indexed citations
14.
Federico, Cinzia, Jennifer Sun, Barbara Muz, et al.. (2020). Localized Delivery of Cisplatin to Cervical Cancer Improves Its Therapeutic Efficacy and Minimizes Its Side Effect Profile. International Journal of Radiation Oncology*Biology*Physics. 109(5). 1483–1494. 48 indexed citations
15.
Zhang, Jin, Naoshad Muhammad, Michael C. Zahner, et al.. (2020). Glutaminase Inhibitors Induce Thiol-Mediated Oxidative Stress and Radiosensitization in Treatment-Resistant Cervical Cancers. Molecular Cancer Therapeutics. 19(12). 2465–2475. 34 indexed citations
16.
Naz, Huma, Mohammad Tarique, Mohd Suhail, et al.. (2020). Calcium-/Calmodulin-Dependent Protein Kinase IV (CAMKIV): A Multifunctional Enzyme and Its Role in Various Cancer: An Update. 6(3). 139–147. 8 indexed citations
17.
Muhammad, Naoshad, Sourav Bhattacharya, Robert Steele, Nancy J. Phillips, & Ratna B. Ray. (2017). Abstract 5761: C-Fos drives non-tumorigenic head and neck squamous cell carcinoma cells to tumorigenic by promoting cancer stem cells like properties. Cancer Research. 77(13_Supplement). 5761–5761.
18.
Bhattacharya, Sourav, Naoshad Muhammad, Robert Steele, Jacki Kornbluth, & Ratna B. Ray. (2017). Bitter Melon Enhances Natural Killer–Mediated Toxicity against Head and Neck Cancer Cells. Cancer Prevention Research. 10(6). 337–344. 67 indexed citations
19.
Muhammad, Naoshad, Sourav Bhattacharya, Robert Steele, Nancy J. Phillips, & Ratna B. Ray. (2016). Involvement of c-Fos in the Promotion of Cancer Stem-like Cell Properties in Head and Neck Squamous Cell Carcinoma. Clinical Cancer Research. 23(12). 3120–3128. 96 indexed citations
20.
Bhattacharya, Sourav, Naoshad Muhammad, Robert Steele, Guangyong Peng, & Ratna B. Ray. (2016). Immunomodulatory role of bitter melon extract in inhibition of head and neck squamous cell carcinoma growth. Oncotarget. 7(22). 33202–33209. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shuqiang Yue Breakdown of academic impact, for papers by Zhenhua Ni Breakdown of academic impact, for papers by Carrie Cartwright Breakdown of academic impact, for papers by Rachana Garg Breakdown of academic impact, for papers by Subhayan Sur Breakdown of academic impact, for papers by Xuanfu Xu Breakdown of academic impact, for papers by Fangtian Fan
Rankless by CCL
2026